Bioadaptives (BDPT) Other Accumulated Expenses (2019 - 2026)

Bioadaptives has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $1032.0 for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $1032.0, up 1.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $1032.0 (up 1.28% YoY), and the FY2025 annual result was $1023.0, changed 0.2% from the prior year.
• Other Accumulated Expenses came in at $1032.0 for Q1 2026 at Bioadaptives, up from $1023.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1032.0 in Q1 2026 to a low of $1015.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $1019.0 (2023), against an average of $1020.5.
• Across the five-year window, Other Accumulated Expenses decreased 0.39% in 2025 and climbed 1.28% in 2026, its largest moves.
• Bioadaptives' Other Accumulated Expenses stood at $1015.0 in 2022, then rose by 0.39% to $1019.0 in 2023, then advanced by 0.2% to $1021.0 in 2024, then grew by 0.2% to $1023.0 in 2025, then advanced by 0.88% to $1032.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $1032.0 (Q1 2026), $1023.0 (Q4 2025), and $1018.0 (Q2 2025), per Business Quant data.